When did neurologists and psychiatrists stop talking to each other?

Epilepsy and Behavior

Volumn 4, Issue 6, 2003, Pages 597-601

  Kanner, Andres M ^a,b  

^a RUSH MEDICAL COLLEGE   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Anxiety disorders; Attention deficit disorders; Depression; Epilepsy surgery; Intractable epilepsy; Psychosis; Temporal lobe epilepsy

Indexed keywords

ANTIDEPRESSANT AGENT; METHYLPHENIDATE; MONOAMINE OXIDASE INHIBITOR; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ANXIETY NEUROSIS; ARTICLE; ATTENTION DEFICIT DISORDER; COMORBIDITY; COOPERATION; DEPRESSION; DISEASE ASSOCIATION; EPILEPSY; HEALTH CARE FACILITY; HUMAN; INTERPERSONAL COMMUNICATION; MEDICAL ASSESSMENT; MEDICAL SPECIALIST; MENTAL DISEASE; NEUROLOGY; NORTH AMERICA; PATIENT ATTITUDE; PATIENT CARE; PREOPERATIVE EVALUATION; PREVALENCE; PSYCHIATRIST; PSYCHOLOGIC ASSESSMENT; PSYCHOSIS; TEMPORAL LOBECTOMY;

EID: 0347418148     PISSN: 15255050     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yebeh.2003.09.013     Document Type: Article

References (33)

1. Feinstein A. Multiple sclerosis and depression. In: Feinstein A, editor. The clinical neuropsychiatry of multiple sclerosis. Cambridge: University Press; 1999. p. 26-50.
2. Minden SL, Schiffer RB. Affective disorders in multiple sclerosis, review and recommendations for clinical research. Arch Neurol 1990;47:98-104.
3. Chwastiak L, Ehde DM, Gibbons LE, et al. Depressive symptoms and severity of illness in multiple sclerosis: epidemiological study of a large community sample. Am J Psychiatry 2002;159:1862-8.
4. Gotham AM, Brown RG, Marsden CD. Depression in Parkinson's disease: a quantitative and qualitative analysis. J Neurol Neurosurg Psychiatry 1986;49:381-9.
5. Robinson RG, Price TR. Post-stroke depressive disorders: a follow-up study of 103 outpatients. Stroke 1982;13:635-41.
6. Kuopio AM, Marttila RJ, Helenius H, et al. The quality of life in Parkinson's disease. Mov Disord 2000;15:216-23.
7. Schrag A, Jahanshahi M, Quinn N. What contributes to quality of life in patients with Parkinson's disease? J Neurol Neurosurg Psychiatry 2000;69:308-12.
8. The Global Parkinson's Disease Survey Steering Committee. Factors impacting on the quality of life in Parkinson's disease: results from an international survey. Mov Disord 2002;17:60-7.
9. Starkstein SE, Robinson RG, Price TR. Comparison of patients with and without post-stroke major depression matched for age and location of lesion. Arch Gen Psychiatry 1988;45:247-52.
10. Robinson RG, Starr LB, Lipsey JR, Rao K, Price TR. A two year longitudinal study of post-stroke mood disorders: in-hospital prognostic factors associated with six month outcome. J Nerv Ment Dis 1985;173:221-6.
11. Robinson RG, Starr LB, Kubos KL, Price TR. A two year longitudinal study of post-stroke mood disorders: findings during the initial evaluation. Stroke 1983;14:736-44.
12. Kimura M, Robinson RG, Kosier T. Treatment of cognitive impairment after poststroke depression. Stroke 2000;31:1482-6.
13. Parikh RM, Robinson RG, Lipsey JR, Starkstein SE, Fedoroff JP, Price TR. The impact of post-stroke depression on recovery in activities of daily living over two year follow-up. Arch Neurol 1990;47:785-9.
14. Chemerinski E, Robinson RG, Arndt S, Kosier JT. The effect of remission of poststroke depression on activities of daily living in a doubleblind randomized treatment study. J Nerv Ment Dis 2001;89:421-5.
15. Wade DT, Legh-Smith J, Hewer RA. Depressed mood after stroke, a community study of its frequency. Br J Psychiatry 1987;151:200-5.
16. Robinson RG, Schultz SK, Castillo C, Kopel T, Kosier T. Nortriptyline versus fluoxetine in the treatment of depression and in short term recovery after stroke: a placebo controlled, double-blind study. Am J Psychiatry 2000;157:351-9.
17. Robinson RG. Poststroke depression: prevalence, diagnosis and disease progression. Biol Psychiatry 2003;54:376-87.
18. Lehrner J, Kalchmayr R, Serles W, et al. Health-related quality of life (HRQOL), activity of daily living (ADL) and depressive mood disorder in temporal lobe epilepsy patients. Seizure 1999;8:88-92.
19. Gilliam F, Kuzniecky R, Meador K, et al. Patient-oriented outcome assessment after temporal lobectomy for refractory epilepsy. Neurology 1999;53:687-94.
20. Gilliam F. Optimizing health outcomes in active epilepsy. Neurology 2002;58(Suppl 5):S9-19.
21. Carson AJ, Postma K, Stone J, Warlow C, Sharpe M. The outcome of depressive disorders in neurology patients: a prospective cohort study. J Neurol Neurosurg Psychiatry 2003;74:893-6.
22. Kanner AM, Balabanov A. Depression and epilepsy: how closely related are they? Neurology 2002;58(Suppl 5):S45-50.
23. Reuber M, Pukrop R, Bauer J, Helmstaedter C, Tessendorf N, Elger CE. Outcome in psychogenic non-epileptic seizures: 4 to 10-year follow-up in 164 patients. Ann Neurol 2003;53:305-11.
24. Harden CL, Tuna Burgut F, Kanner AM. The diagnostic significance of video-EEG monitoring findings on pseudoseizure patients differ between neurologists and psychiatrists. Epilepsia 2003;44:453-6.
25. Blumer D, Wakhlu S, Davies K, Hermann B. Psychiatric outcome of temporal lobectomy for epilepsy: incidence and treatment of psychiatric complications. Epilepsia 1998;39:478-86.
26. Taylor DC. Factors influencing the occurrence of schizophrenia-like psychosis in patients with temporal lobe epilepsy. Psychol Med 1975;5:249-54.
27. Jensen I, Vaernet K. Temporal lobe epilepsy: follow-up investigation of 74 temporal lobe resected patients. Acta Neurochirurg 1977;37:173-200.
28. Trimble MR. Behaviour changes following temporal lobectomy, with special reference to psychosis (editorial). J Neurol Neurosurg Psychiatry 1992;55:89-91.
29. Blumer D. Antidepressant and double antidepressant treatment for the affective disorder of epilepsy. J Clin Psychiatry 1997;58:3-11.
30. Kanner AM, Kozak AM, Frey M. The use of sertraline in patients with epilepsy: is it safe? Epilepsy Behav 2000;1:100-5.
31. Mendez MF, Cummings J, Benson D, et al. Depression in epilepsy: significance and phenomenology. Arch Neurol 1986;43:766-70.
32. Dunn DW. Attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder. In: Ettinger AB, Kanner AM, editors. Psychiatric issues in epilepsy: a practical guide to diagnosis and treatment. Philadelphia, Lippincott: Williams Wilkins; 2001. p. 111-26.
33. Sheline YI, Sanghavi M, Mintun MA, et al. Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J Neurosci 1999;19:5034-43.